DASbox® Mini Bioreactor System: In the Quality by Design (QbD) and Process Analytical Technology (PAT) era, the generation and validation of a large amount of data have become standard. Parallel bioreactor control systems offer the possibility to test and optimize different process parameters at the same time, thus saving time and resources.
Oxular Ltd raises US$37m
Latest NewsBritish Oxular Ltd has raised $37m in a financing round led by Forbion Parners and co-financed by IP Group, NeoMed, and V-Bio Ventures to push its pipeline.
EU life science PPPs face less budget in Horizon Europe
Latest NewsThe European Commission is set to fund ten "European Partnerships" partnered with different industries with €10bn.
MosaMeat BV closes US$85m Series B financing
Latest NewsCultured meat producer MosaMeat BV has announced the third and final closing of its Series B round raising US$85m.
Knowledge Gain Through High Parallel Bioprocess Setups
ProductsDASbox® Mini Bioreactor System: In the Quality by Design (QbD) and Process Analytical Technology (PAT) era, the generation and validation of a large amount of data have become standard. Parallel bioreactor control systems offer the possibility to test and optimize different process parameters at the same time, thus saving time and resources.
New CEO of the Novo Nordisk Foundation
AppointmentsMads Krogsgaard Thomsen, CSO at Novo Nordisk, will take up the position as CEO of the Novo Nordisk Foundation effective from 1 March 2021.
Biomarker identifies high-risk COVID-19 patients
Latest NewsAustrian researchers have found that a lack of activation of the NK receptor is highly associated with severe COVID-19 disease courses.
Management changes at Abliva
AppointmentsLund-based Abliva AB named Dr Ellen Donnelly as its new CEO. At the beginning of February she succeeded Dr Erik Kinnmann, who had been CEO since 2018.
MaxiVAX and Minaris Regenerative Medicine ink contract
Latest NewsSwiss cancer vaccine specialist MaxiVAX SA has hired Minaris Regenerative Medicine GmbH to produce its cell therapy MVX-ONCO-2.
EU orders additional COVID-19 vaccine doses
Latest NewsPfizer Inc. and BioNTech SE have signed an agreement with the European Commission (EC) to supply an additional 200 million doses of BNT162b2 to the EU.
Novel strategy targets chronic liver diseases
Latest NewsA resesarch team headed by HepaRegeneriX Board Member Lars Zender has presented a new approach to treat hepatocellular carcinoma (HCC) by disturbing the lipid metabolism of tumour cells.